Hematology News and Research

RSS

Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases.

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

The newly established research program, 'Program for Translational Hematology', has just received DKK 100 million in funding from the Novo Nordisk Foundation.

From Novo Nordisk 24 Aug 2017

Scientists develop new system to identify and characterize regulatory DNA sequences

Scientists from the Children's Medical Center Research Institute at UT Southwestern have developed an innovative system to identify and characterize the molecular components that control the activities of regulatory DNA sequences in the human genome.

24 Aug 2017

Medical experts explore different ways to enhance situation of patients with myelodysplastic syndromes

More than 70 leading medical specialists, nurses, patient advocates, researchers, regulatory / Health Technology Assessment experts and industry representatives gathered on 3 May 2017 in Valencia, Spain to discuss existing challenges and what is needed to improve the situation of patients affected by myelodysplastic syndromes (MDS).

18 Aug 2017

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) today approved Besponsa (inotuzumab ozogamicin) in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) - a rare form of ALL.

17 Aug 2017

$FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL$

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).

17 Aug 2017

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Investigators at Children's Hospital Los Angeles have succeeded in better defining a rare pediatric malignant liver disease -- a necessary step in achieving an optimum treatment.

9 Aug 2017

Postoperative patients use fewer opioid medications than prescribed after hernia surgery

A study by investigators from Massachusetts General Hospital and Newton-Wellesley Hospital found that patients prescribed opioid medications after inguinal (groin) hernia surgery used significantly fewer tablets than prescribed, even though they had received fewer than typically administered for such surgery.

9 Aug 2017

Clinical trial shows safety, effectiveness of pre-prepared cells to treat drug-resistant viral infections

Patients who receive a hematopoietic stem cell transplant are at risk of developing potentially lethal viral infections. Some of the infections can be treated with available drugs, but they are not always effective and side effects can be significant.

8 Aug 2017

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

The U.S. Food and Drug Administration (FDA) yesterday approved Vyxeos - a fixed dose combination chemotherapy for the treatment of adults with two types of acute myeloid leukemia (AML). The types of AML that would be treated with Vyxeos include newly diagnosed therapy-related AML (t-AML) and AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of the chemotherapy drugs daunorubicin and cytarabine.

3 Aug 2017

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

3 Aug 2017

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.

2 Aug 2017

Shaping the future of oncology treatment

Victories Over Cancer is about enabling those affected by cancer to enjoy more of life’s meaning full moments and making cancer more manageable. At Janssen, we're really thinking about the elimination of cancer, and we take a very deliberate approach to that.

2 Aug 2017

$New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod$

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

The U.S. Food and Drug Administration (FDA) in a statement yesterday reported its approval for a new drug, Idhifa (enasidenib) for the treatment of acute myeloid leukemia (AML) in adults that has either relapsed or is refractory to standard chemotherapy.

2 Aug 2017

Hematology News and Research

Further Reading

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

Scientists develop new system to identify and characterize regulatory DNA sequences

Medical experts explore different ways to enhance situation of patients with myelodysplastic syndromes

FDA approves Besponsa – Pfizer’s new drug for rare form of acute lymphoblastic leukemia

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Postoperative patients use fewer opioid medications than prescribed after hernia surgery

Clinical trial shows safety, effectiveness of pre-prepared cells to treat drug-resistant viral infections

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Sheffield scientists discover that simple arthritis drug could help treat blood cancer sufferers

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Shaping the future of oncology treatment

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

Expanding clinical flow cytometry portfolio unveiled by Beckman Coulter at AACC

Case Western Reserve University professor awarded $150,000 for pediatric cancer research

Researchers discover potential chemical 'silver bullet' to reduce risk of colon cancer

Researchers show how hematopoietic stem cells detect and react to infections

FDA approves first extended adjuvant therapy to lower risk of breast cancer recurrence

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance

New treatment receives FDA approval to reduce complications of sickle cell disease

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo